Roland is Chief Financial Officer and Managing Director of QIAGEN N.V. and joined IDS in 2011 as Non-executive Director and Chair of the Audit Committee. As CFO, Roland spearheads the creation and execution of long-term financial plans which enable QIAGEN to execute its accelerated growth strategy. He was responsible for numerous financing activities both on the equity side and the debt capital side with a total value of more than US$3bn, which supported more than 25 M&A transactions and led to significant revenue and profit growth. Roland holds a Masters Degree in Business Administration (Diploma Kaufmann) from the University of Münster. He joined QIAGEN in 1999 and has been CFO since 2004. He topped ratings of Biotech CFO’s in a survey released by Thomson Reuters in 2011. Prior to joining QIAGEN, he acted as an auditor with Arthur Andersen. Roland is a Board member of the industry association BIO Deutschland as well as member of the board of directors and head of the audit committee of QIAGEN Marseille (formerly Ipsogen S.A.).

 Management